يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"pathologically high-risk"', وقت الاستعلام: 0.94s تنقيح النتائج
  1. 1
    دورية أكاديمية
    NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer.

    المؤلفون: Bauman, Julie E, Harris, Jonathan, Uppaluri, Ravindra, Yao, Min, Ferris, Robert L, Chen, Josephine, Jordan, Richard C, Joshi, Nikhil P, Jujjuvaparu, Srinivas, Blakaj, Dukagjin M, Henson, Christina, Sheqwara, Jawad, Mell, Loren K, Sen, Neilayan, Clump, David A, Garg, Madhur K, Yilmaz, Emrullah, Torres-Saavedra, Pedro, Le, Quynh-Thu

    المصدر: Cancers. 13(12)

    مصطلحات موضوعية: adjuvant, cisplatin, head and neck cancer, pathologically high-risk, pembrolizumab, phase I, radiation therapy, Oncology and Carcinogenesis

    وصف الملف: application/pdf

    URL الوصول: https://escholarship.org/uc/item/1j11w57z

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer

    المؤلفون: Julie E. Bauman, Jonathan Harris, Ravindra Uppaluri, Min Yao, Robert L. Ferris, Josephine Chen, Richard C. Jordan, Nikhil P. Joshi, Srinivas Jujjuvaparu, Dukagjin M. Blakaj, Christina Henson, Jawad Sheqwara, Loren K. Mell, Neilayan Sen, David A. Clump, Madhur K. Garg, Emrullah Yilmaz, Pedro Torres-Saavedra, Quynh-Thu Le

    المصدر: Cancers, Vol 13, Iss 12, p 2882 (2021)

    مصطلحات موضوعية: head and neck cancer, pathologically high-risk, pembrolizumab, adjuvant, radiation therapy, cisplatin, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    Relation: https://www.mdpi.com/2072-6694/13/12/2882; https://doaj.org/toc/2072-6694

    URL الوصول: https://doaj.org/article/c23bfc0b2f824547ae794694e7e3ac56

    Find this article in full text from ProQuest Full Text Finder
    أضف إلى المفضلة
  3. 3
    NRG-HN003: Phase I and Expansion Cohort Study of Adjuvant Pembrolizumab, Cisplatin and Radiation Therapy in Pathologically High-Risk Head and Neck Cancer

    المؤلفون: Neilayan Sen, Min Yao, Loren K. Mell, Quynh-Thu Le, David A. Clump, Nikhil P. Joshi, Robert L. Ferris, Josephine Chen, Richard C.K. Jordan, Srinivas Jujjuvaparu, Dukagjin Blakaj, Emrullah Yilmaz, Pedro A. Torres-Saavedra, Ravindra Uppaluri, Christina Henson, Madhur Garg, Jonathan Harris, Jawad Sheqwara, Julie E. Bauman

    المصدر: Cancers, vol 13, iss 12
    Cancers
    Volume 13
    Issue 12
    Cancers, Vol 13, Iss 2882, p 2882 (2021)

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Oncology and Carcinogenesis, cisplatin, Pembrolizumab, radiation therapy, Article, 03 medical and health sciences, 0302 clinical medicine, Rare Diseases, adjuvant, Clinical Research, Internal medicine, Medicine, Dental/Oral and Craniofacial Disease, Adverse effect, RC254-282, Cancer, business.industry, Head and neck cancer, pathologically high-risk, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, phase I, medicine.disease, Head and neck squamous-cell carcinoma, Radiation therapy, Regimen, 030104 developmental biology, Infectious Diseases, 030220 oncology & carcinogenesis, Cohort, head and neck cancer, pembrolizumab, business, Digestive Diseases, Cohort study

    وصف الملف: application/pdf

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::957bb4dffc33f6d2401974e1408b2522
    https://escholarship.org/uc/item/1j11w57z

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء